Skip to content
MedsAcross

Manufacturer

Key Therapeutics

Products listed
3
Molecules
2
Therapy areas
1

Key Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 3 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Key Therapeutics products through licensed channels, with the documents your regulator needs.

Psychiatry

1 presentation

Psychiatry overview
MedicineActive ingredientRegisterAvailability
Imipramine 25 mg tabletOralGeneric nameImipramineUS FDAAvailable on request

Other products

2 presentations

MedicineActive ingredientRegisterAvailability
Methocarbamol 500 mg tabletOralGeneric nameMethocarbamolUS FDAAvailable on request
Methocarbamol 750 mg tabletOralGeneric nameMethocarbamolUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Key Therapeutics

Send a request for any of these products. We confirm the licensed source, documents and lead time.